Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nan Ya Plastics Corporation (1303.TW)
Kaohsiung, TW
Established in 1958 and headquartered in Kaohsiung City, Taiwan, Nan Ya Plastics Corporation is a major global manufacturer and distributor. The company's extensive portfolio encompasses a broad spectrum of products, including plastics, polyester fibers, petrochemicals, and electronic materials, serving markets across Taiwan, China, Hong Kong, the United States, and internationally. Its diverse offerings feature a wide array of plastic products, ranging from various films (such as synthetic, optical, cling, stretch, BOPP, and CPP) and sheets (including PVC, PP, and A-PET rigid types) to synthetic leather, adhesives, construction materials like pipes, fittings, fire-rated doors and windows, and specialized engineering and PVC compounds. In the electronics sector, Nan Ya Plastics supplies critical components like copper clad laminates, glass fabrics, LCD products, touch panels, copper foils, and PCB inks. The chemicals division produces essential substances such as plasticizers, alcohols, glycols, curing agents, hydrogen peroxide, various anhydrides, and epoxy resins. For the textile industry, it provides a comprehensive range of fiber and textile products, including different types of yarns, polyester staple fibers, PET resins, polyester films, and both woven and knitting fabrics. Additionally, the company manufactures and supplies machinery and switchgear products, comprising high and low voltage switchgears, cast resin transformers, and industrial components like molds, rollers, and screws and barrels.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.92% | -3.35% | +0.93% | +3.47% | +60.78% | +43.69% | +176.36% | +11.33% | +9.49% | +45.38% | +196.64% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | +1 |
| Hold | 3 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +7.2%+0.1% Q1'26: +4.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +16.5%+35.7% ★ Q1'26: +3,052.4% (vs Q1'25)
-
FCF margin Chemicals - Specialty: +27.4%-1.7% Q1'26: -6.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +9.5%+1.4% Q1'26: +5.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +6.2%+0.6% Q1'26: +2.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Chemicals - Specialty: 0.21×6.61× Q1'26: 4.38× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 3 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
299.78B
est: 305.01B (-1.7%)
|
275.29B
est: 275.98B (-0.2%)
|
306.14B
est: 312.82B (-2.1%)
|
333.06B
est: 333.06B (+0.0%)
|
286.30B
est: 288.82B (-0.9%)
|
273.35B
est: 278.25B (-1.8%)
|
411.67B
est: 405.04B (+1.6%)
|
355.18B
est: 362.80B (-2.1%)
|
259.76B
est: 255.28B (+1.8%)
|
259.61B
est: 258.60B (+0.4%)
|
259.92B
est: 261.12B (-0.5%)
|
287.33B
275.68B – 298.98B
+10.0% YoY
|
318.61B
299.09B – 358.29B
+10.9% YoY
|
372.21B
353.22B – 403.14B
+16.8% YoY
|
| EBITDA |
43.67B
est: 57.09B (-23.5%)
|
45.66B
est: 51.65B (-11.6%)
|
51.09B
est: 58.55B (-12.7%)
|
54.92B
est: 62.33B (-11.9%)
|
44.85B
est: 54.05B (-17.0%)
|
48.53B
est: 52.08B (-6.8%)
|
124.76B
est: 75.81B (+64.6%)
|
70.41B
est: 67.90B (+3.7%)
|
36.57B
est: 43.86B (-16.6%)
|
30.16B
est: 44.43B (-32.1%)
|
26.21B
est: 44.86B (-41.6%)
|
49.37B
47.37B – 51.37B
+10.0% YoY
|
54.74B
51.39B – 61.56B
+10.9% YoY
|
63.95B
60.69B – 69.27B
+16.8% YoY
|
| EBIT |
18.60B
est: 36.04B (-48.4%)
|
55.42B
est: 32.61B (+70.0%)
|
29.85B
est: 36.96B (-19.2%)
|
29.42B
est: 39.35B (-25.2%)
|
28.31B
est: 34.13B (-17.0%)
|
31.75B
est: 32.88B (-3.4%)
|
104.97B
est: 47.86B (+119.3%)
|
49.86B
est: 42.87B (+16.3%)
|
13.13B
est: 24.96B (-47.4%)
|
7.46B
est: 25.28B (-70.5%)
|
3.69B
est: 25.53B (-85.5%)
|
28.09B
26.95B – 29.23B
+10.0% YoY
|
31.15B
29.24B – 35.03B
+10.9% YoY
|
36.39B
34.53B – 39.41B
+16.8% YoY
|
| Net Income |
35.72B
est: 36.22B (-1.4%)
|
48.84B
est: 44.80B (+9.0%)
|
54.52B
est: 52.76B (+3.3%)
|
52.75B
est: 52.16B (+1.1%)
|
23.08B
est: 23.50B (-1.8%)
|
25.71B
est: 24.29B (+5.8%)
|
81.30B
est: 80.60B (+0.9%)
|
32.11B
est: 33.95B (-5.4%)
|
6.31B
est: 7.48B (-15.6%)
|
3.34B
est: 3.19B (+4.6%)
|
4.52B
est: 4.52B (+0.0%)
|
47.76B
41.91B – 48.92B
+956.9% YoY
|
41.93B
21.50B – 84.04B
-12.2% YoY
|
77.55B
72.42B – 85.94B
+84.9% YoY
|
| SGA |
17.76B
est: 19.57B (-9.2%)
|
18.12B
est: 17.70B (+2.3%)
|
20.12B
est: 20.07B (+0.3%)
|
19.64B
est: 21.36B (-8.1%)
|
18.25B
est: 18.53B (-1.5%)
|
18.38B
est: 17.85B (+3.0%)
|
22.80B
est: 25.98B (-12.2%)
|
21.86B
est: 23.27B (-6.0%)
|
17.23B
est: 16.46B (+4.7%)
|
18.23B
est: 16.67B (+9.3%)
|
17.91B
est: 16.84B (+6.4%)
|
18.53B
17.78B – 19.28B
+10.0% YoY
|
20.54B
19.28B – 23.10B
+10.9% YoY
|
24.00B
22.77B – 25.99B
+16.8% YoY
|
| EPS |
4.50
est: 4.57 (-1.5%)
|
6.16
est: 5.65 (+9.1%)
|
6.87
est: 6.65 (+3.3%)
|
6.65
est: 6.58 (+1.1%)
|
2.91
est: 2.96 (-1.8%)
|
3.24
est: 3.06 (+5.8%)
|
10.25
est: 10.16 (+0.9%)
|
4.05
est: 4.23 (-4.2%)
|
0.80
est: 0.94 (-15.2%)
|
0.42
est: 0.39 (+6.5%)
|
0.57
est: 0.58 (-1.9%)
|
5.72
5.28 – 6.17
+885.4% YoY
|
6.89
2.71 – 10.60
+20.4% YoY
|
9.78
9.13 – 10.84
+41.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-15 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-14 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-13 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-10 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ming-Jen Tzou | Manager, President & Director | 14M | male |
| Yeou-Ming Ko | Senior Vice President & Director | 6M | male |
| Yu-Sheng Chen | Senior Vice President & Director | 6M | male |
| Kuei-Yung Wang | Senior Vice President & Director | 6M | female |
| Chang-Ming Tsai | Senior Vice President | 5M | male |
| Yu-Lung Huang | Vice President | 5M | male |
| Hong-Cheng Yan | Vice President | 5M | — |
| Ruey-Yu Wang | MD & Executive Director | 60.0K | female |
| Wen-Chiao Wang | MD & Director | 40.0K | male |
| Wen-Yuan Wong | MD & Director | 40.0K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1303.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
